{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:29:03Z","timestamp":1791412143011,"version":"4.3.3"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-025-01579-5","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T08:18:19Z","timestamp":1750148299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pyroptosis in Alzheimer\u2019s Disease: Mechanisms and Therapeutic Potential"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2690-3063","authenticated-orcid":false,"given":"Tian","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"issue":"28","key":"1579_CR1","doi-asserted-by":"publisher","first-page":"7858","DOI":"10.1073\/pnas.1607769113","volume":"113","author":"RA Aglietti","year":"2016","unstructured":"Aglietti RA, Estevez A, Gupta A, Ramirez MG, Liu PS, Kayagaki N, Ciferri C, Dixit VM, Dueber EC (2016) GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc Natl Acad Sci USA 113(28):7858\u20137863. https:\/\/doi.org\/10.1073\/pnas.1607769113","journal-title":"Proc Natl Acad Sci USA"},{"key":"1579_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.trsl.2022.08.006","volume":"252","author":"FL Anderson","year":"2023","unstructured":"Anderson FL, Biggs KE, Rankin BE, Havrda MC (2023) NLRP3 inflammasome in neurodegenerative disease. Translat Res J Lab Clin Med 252:21\u201333. https:\/\/doi.org\/10.1016\/j.trsl.2022.08.006","journal-title":"Translat Res J Lab Clin Med"},{"key":"1579_CR3","doi-asserted-by":"publisher","unstructured":"Anton PE, Nagpal P, Moreno J, Burchill MA, Chatterjee A, Busquet N, Mesches M, Kovacs EJ, McCullough RL (2024) NF-\u03baB\/NLRP3 Translational inhibition by nanoligomer therapy mitigates ethanol and advanced age-related neuroinflammation. bioRxiv : the preprint server for biology. https:\/\/doi.org\/10.1101\/2024.02.26.582114","DOI":"10.1101\/2024.02.26.582114"},{"key":"1579_CR4","doi-asserted-by":"publisher","first-page":"105255","DOI":"10.1016\/j.bioorg.2021.105255","volume":"115","author":"Y Bai","year":"2021","unstructured":"Bai Y, Liu D, Zhang H, Wang Y, Wang D, Cai H, Wen H, Yuan G, An H, Wang Y, Shi T, Wang Z (2021) N-salicyloyl tryptamine derivatives as potential therapeutic agents for Alzheimer\u2019s disease with neuroprotective effects. Bioorg Chem 115:105255. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105255","journal-title":"Bioorg Chem"},{"key":"1579_CR5","doi-asserted-by":"publisher","first-page":"108595","DOI":"10.1016\/j.intimp.2022.108595","volume":"106","author":"S Bakhshi","year":"2022","unstructured":"Bakhshi S, Shamsi S (2022) MCC950 in the treatment of NLRP3-mediated inflammatory diseases: latest evidence and therapeutic outcomes. Int Immunopharmacol 106:108595. https:\/\/doi.org\/10.1016\/j.intimp.2022.108595","journal-title":"Int Immunopharmacol"},{"issue":"2\u20133","key":"1579_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejphar.2010.05.030","volume":"641","author":"A Baraka","year":"2010","unstructured":"Baraka A, ElGhotny S (2010) Study of the effect of inhibiting galanin in Alzheimer\u2019s disease induced in rats. Eur J Pharmacol 641(2\u20133):123\u2013127. https:\/\/doi.org\/10.1016\/j.ejphar.2010.05.030","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1579_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12974-021-02099-x","volume":"18","author":"AF Batista","year":"2021","unstructured":"Batista AF, Rody T, Forny-Germano L, Cerdeiro S, Bellio M, Ferreira ST, Munoz DP, De Felice FG (2021) Interleukin-1\u03b2 mediates alterations in mitochondrial fusion\/fission proteins and memory impairment induced by amyloid-\u03b2 oligomers. J Neuroinflammation 18(1):54. https:\/\/doi.org\/10.1186\/s12974-021-02099-x","journal-title":"J Neuroinflammation"},{"issue":"4","key":"1579_CR8","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/alz.13016","volume":"19","author":"MA Better","year":"2023","unstructured":"Better MA (2023) Alzheimer\u2019s disease facts and figures. Alzheimers Dement 19(4):1598\u20131695. https:\/\/doi.org\/10.1002\/alz.13016","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1579_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.eplepsyres.2012.10.001","volume":"103","author":"M Bialer","year":"2013","unstructured":"Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS (2013) Progress report on new antiepileptic drugs: a summary of the eleventh eilat conference (EILAT XI). Epilepsy Res 103(1):2\u201330. https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.10.001","journal-title":"Epilepsy Res"},{"issue":"1\u20132","key":"1579_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","volume":"202","author":"D Blum-Degen","year":"1995","unstructured":"Blum-Degen D, M\u00fcller T, Kuhn W, Gerlach M, Przuntek H, Riederer P (1995) Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients. Neurosci Lett 202(1\u20132):17\u201320. https:\/\/doi.org\/10.1016\/0304-3940(95)12192-7","journal-title":"Neurosci Lett"},{"issue":"2","key":"1579_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s0966-842x(00)01937-5","volume":"9","author":"LH Boise","year":"2001","unstructured":"Boise LH, Collins CM (2001) Salmonella-induced cell death: apoptosis, necrosis or programmed cell death? Trends Microbiol 9(2):64\u201367. https:\/\/doi.org\/10.1016\/s0966-842x(00)01937-5","journal-title":"Trends Microbiol"},{"key":"1579_CR12","doi-asserted-by":"publisher","first-page":"809433","DOI":"10.3389\/fnagi.2021.809433","volume":"13","author":"Y Cai","year":"2021","unstructured":"Cai Y, Chai Y, Fu Y, Wang Y, Zhang Y, Zhang X, Zhu L, Miao M, Yan T (2021) Salidroside ameliorates Alzheimer\u2019s disease by targeting NLRP3 inflammasome-mediated pyroptosis. Front Aging Neurosci 13:809433. https:\/\/doi.org\/10.3389\/fnagi.2021.809433","journal-title":"Front Aging Neurosci"},{"issue":"1\u20132","key":"1579_CR13","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s10495-024-02041-5","volume":"30","author":"L Cai","year":"2025","unstructured":"Cai L, Fan Q, Pang R, Chen C, Zhang Y, Xie H, Huang J, Wang Y, Li P, Huang D, Jin X, Zhou Y, Li Y (2025) Microglia programmed cell death in neurodegenerative diseases and CNS injury. Apoptosis: an Int J Program Cell Death 30(1\u20132):446\u2013465. https:\/\/doi.org\/10.1007\/s10495-024-02041-5","journal-title":"Apoptosis: an Int J Program Cell Death"},{"issue":"5\u20136","key":"1579_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000360606","volume":"38","author":"JM Chen","year":"2014","unstructured":"Chen JM, Jiang GX, Li QW, Zhou ZM, Cheng Q (2014) Increased serum levels of interleukin-18, -23 and -17 in Chinese patients with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 38(5\u20136):321\u2013329. https:\/\/doi.org\/10.1159\/000360606","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"9","key":"1579_CR15","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/cr.2016.100","volume":"26","author":"X Chen","year":"2016","unstructured":"Chen X, He WT, Hu L, Li J, Fang Y, Wang X, Xu X, Wang Z, Huang K, Han J (2016) Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Res 26(9):1007\u20131020. https:\/\/doi.org\/10.1038\/cr.2016.100","journal-title":"Cell Res"},{"issue":"6","key":"1579_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3892\/etm.2021.9989","volume":"21","author":"L Cheng","year":"2021","unstructured":"Cheng L, Zhang W (2021) DJ-1 affects oxidative stress and pyroptosis in hippocampal neurons of Alzheimer\u2019s disease mouse model by regulating the Nrf2 pathway. Exp Ther Med 21(6):557. https:\/\/doi.org\/10.3892\/etm.2021.9989","journal-title":"Exp Ther Med"},{"issue":"3","key":"1579_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Mu\u00f1oz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG, Stutz A, Croker DE, Butler MS, Haneklaus M, Sutton CE, N\u00fa\u00f1ez G, Latz E, Kastner DL, Mills KH, Masters SL, Schroder K, Cooper MA, O\u2019Neill LA (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21(3):248\u2013255. https:\/\/doi.org\/10.1038\/nm.3806","journal-title":"Nat Med"},{"issue":"3","key":"1579_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/s0966-842x(00)01936-3","volume":"9","author":"BT Cookson","year":"2001","unstructured":"Cookson BT, Brennan MA (2001) Pro-inflammatory programmed cell death. Trends Microbiol 9(3):113\u2013114. https:\/\/doi.org\/10.1016\/s0966-842x(00)01936-3","journal-title":"Trends Microbiol"},{"issue":"1","key":"1579_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nn.2709","volume":"14","author":"M D\u2019Amelio","year":"2011","unstructured":"D\u2019Amelio M, Cavallucci V, Middei S, Marchetti C, Pacioni S, Ferri A, Diamantini A, De Zio D, Carrara P, Battistini L, Moreno S, Bacci A, Ammassari-Teule M, Marie H, Cecconi F (2011) Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer\u2019s disease. Nat Neurosci 14(1):69\u201376. https:\/\/doi.org\/10.1038\/nn.2709","journal-title":"Nat Neurosci"},{"issue":"2","key":"1579_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/08830185.2024.2415688","volume":"44","author":"M Dadkhah","year":"2025","unstructured":"Dadkhah M, Sharifi M (2025) The NLRP3 inflammasome: mechanisms of activation, regulation, and role in diseases. Int Rev Immunol 44(2):98\u2013111. https:\/\/doi.org\/10.1080\/08830185.2024.2415688","journal-title":"Int Rev Immunol"},{"issue":"16","key":"1579_CR21","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/s0047-6374(01)00313-x","volume":"122","author":"A De Luigi","year":"2001","unstructured":"De Luigi A, Fragiacomo C, Lucca U, Quadri P, Tettamanti M, Grazia De Simoni M (2001) Inflammatory markers in Alzheimer\u2019s disease and multi-infarct dementia. Mech Ageing Dev 122(16):1985\u20131995. https:\/\/doi.org\/10.1016\/s0047-6374(01)00313-x","journal-title":"Mech Ageing Dev"},{"issue":"3","key":"1579_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/jcbfm.2013.227","volume":"34","author":"JP de Rivero Vaccari","year":"2014","unstructured":"de Rivero Vaccari JP, Dietrich WD, Keane RW (2014) Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury. J Cereb Blood Flow Metabol: off J Int Soc Cereb Blood Flow Metab 34(3):369\u2013375. https:\/\/doi.org\/10.1038\/jcbfm.2013.227","journal-title":"J Cereb Blood Flow Metabol: off J Int Soc Cereb Blood Flow Metab"},{"key":"1579_CR23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey C, Rubio Araiz A, Bryson KJ, Finucane O, Larkin C, Mills EL, Robertson AAB, Cooper MA, O\u2019Neill LAJ, Lynch MA (2017) Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice. Brain Behav Immun 61:306\u2013316. https:\/\/doi.org\/10.1016\/j.bbi.2016.12.014","journal-title":"Brain Behav Immun"},{"issue":"5","key":"1579_CR24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1365-2125.2011.03958.x","volume":"71","author":"EA Dubois","year":"2011","unstructured":"Dubois EA, Rissmann R, Cohen AF (2011) Rilonacept and canakinumab. Br J Clin Pharmacol 71(5):639\u2013641. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.03958.x","journal-title":"Br J Clin Pharmacol"},{"key":"1579_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.brainresbull.2018.01.001","volume":"137","author":"MH Esmaeili","year":"2018","unstructured":"Esmaeili MH, Bahari B, Salari AA (2018) ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer\u2019s disease. Brain Res Bull 137:265\u2013276. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.01.001","journal-title":"Brain Res Bull"},{"key":"1579_CR26","doi-asserted-by":"publisher","first-page":"109595","DOI":"10.1016\/j.biopha.2019.109595","volume":"121","author":"Y Fang","year":"2020","unstructured":"Fang Y, Tian S, Pan Y, Li W, Wang Q, Tang Y, Yu T, Wu X, Shi Y, Ma P, Shu Y (2020) Pyroptosis: a new frontier in cancer. Biomed Pharmacother 121:109595. https:\/\/doi.org\/10.1016\/j.biopha.2019.109595","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1579_CR27","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1600-0536.1992.tb03263.x","volume":"27","author":"JC Fern\u00e1ndez","year":"1992","unstructured":"Fern\u00e1ndez JC, Gamboa P, J\u00e1uregui I, Gonz\u00e1lez G, Ant\u00e9para I (1992) Concomitant sensitization to enoxolone and mafenide in a topical medicament. Contact Dermatitis 27(4):262. https:\/\/doi.org\/10.1111\/j.1600-0536.1992.tb03263.x","journal-title":"Contact Dermatitis"},{"issue":"1","key":"1579_CR28","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1038\/s41467-018-06449-x","volume":"9","author":"J Flores","year":"2018","unstructured":"Flores J, No\u00ebl A, Foveau B, Lynham J, Lecrux C, LeBlanc AC (2018) Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer\u2019s disease mouse model. Nat Commun 9(1):3916. https:\/\/doi.org\/10.1038\/s41467-018-06449-x","journal-title":"Nat Commun"},{"issue":"1","key":"1579_CR29","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1038\/s41467-020-18405-9","volume":"11","author":"J Flores","year":"2020","unstructured":"Flores J, No\u00ebl A, Foveau B, Beauchet O, LeBlanc AC (2020) Pre-symptomatic caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging. Nat Commun 11(1):4571. https:\/\/doi.org\/10.1038\/s41467-020-18405-9","journal-title":"Nat Commun"},{"issue":"10","key":"1579_CR30","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41419-022-05290-x","volume":"13","author":"J Flores","year":"2022","unstructured":"Flores J, Fillion ML, LeBlanc AC (2022a) Caspase-1 inhibition improves cognition without significantly altering amyloid and inflammation in aged Alzheimer disease mice. Cell Death Dis 13(10):864. https:\/\/doi.org\/10.1038\/s41419-022-05290-x","journal-title":"Cell Death Dis"},{"issue":"3","key":"1579_CR31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41418-021-00881-1","volume":"29","author":"J Flores","year":"2022","unstructured":"Flores J, No\u00ebl A, Fillion ML, LeBlanc AC (2022b) Therapeutic potential of Nlrp1 inflammasome, Caspase-1, or Caspase-6 against Alzheimer disease cognitive impairment. Cell Death Differ 29(3):657\u2013669. https:\/\/doi.org\/10.1038\/s41418-021-00881-1","journal-title":"Cell Death Differ"},{"issue":"Suppl 1","key":"1579_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jnc.13217","volume":"136","author":"LC Freeman","year":"2016","unstructured":"Freeman LC, Ting JP (2016) The pathogenic role of the inflammasome in neurodegenerative diseases. J Neurochem 136(Suppl 1):29\u201338. https:\/\/doi.org\/10.1111\/jnc.13217","journal-title":"J Neurochem"},{"issue":"11","key":"1579_CR33","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1016\/j.celrep.2020.02.025","volume":"30","author":"LL Friker","year":"2020","unstructured":"Friker LL, Scheiblich H, Hochheiser IV, Brinkschulte R, Riedel D, Latz E, Geyer M, Heneka MT (2020) \u03b2-Amyloid Clustering around ASC fibrils boosts its toxicity in microglia. Cell Rep 30(11):3743-3754.e3746. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.025","journal-title":"Cell Rep"},{"issue":"3","key":"1579_CR34","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3233\/jad-230133","volume":"94","author":"XX Fu","year":"2023","unstructured":"Fu XX, Wei B, Cao HM, Duan R, Deng Y, Lian HW, Zhang YD, Jiang T (2023) Telmisartan alleviates Alzheimer\u2019s disease-related neuropathologies and cognitive impairments. J Alzheimer\u2019s Dis: JAD 94(3):919\u2013933. https:\/\/doi.org\/10.3233\/jad-230133","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"8","key":"1579_CR35","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9(8):857\u2013865. https:\/\/doi.org\/10.1038\/ni.1636","journal-title":"Nat Immunol"},{"issue":"6","key":"1579_CR36","doi-asserted-by":"publisher","first-page":"e01627","DOI":"10.1002\/brb3.1627","volume":"10","author":"C Han","year":"2020","unstructured":"Han C, Guo L, Yang Y, Guan Q, Shen H, Sheng Y, Jiao Q (2020a) Mechanism of microRNA-22 in regulating neuroinflammation in Alzheimer\u2019s disease. Brain Behavior 10(6):e01627. https:\/\/doi.org\/10.1002\/brb3.1627","journal-title":"Brain Behavior"},{"issue":"14","key":"1579_CR37","doi-asserted-by":"publisher","first-page":"8078","DOI":"10.1111\/jcmm.15439","volume":"24","author":"C Han","year":"2020","unstructured":"Han C, Yang Y, Guan Q, Zhang X, Shen H, Sheng Y, Wang J, Zhou X, Li W, Guo L, Jiao Q (2020b) New mechanism of nerve injury in Alzheimer\u2019s disease: \u03b2-amyloid-induced neuronal pyroptosis. J Cell Mol Med 24(14):8078\u20138090. https:\/\/doi.org\/10.1111\/jcmm.15439","journal-title":"J Cell Mol Med"},{"key":"1579_CR38","doi-asserted-by":"publisher","first-page":"105303","DOI":"10.1016\/j.ejps.2020.105303","volume":"147","author":"C Han","year":"2020","unstructured":"Han C, Yang Y, Yu A, Guo L, Guan Q, Shen H, Jiao Q (2020c) Investigation on the mechanism of mafenide in inhibiting pyroptosis and the release of inflammatory factors. Eur J Pharmaceut Sci: off J Eur Feder Pharmaceut Sci 147:105303. https:\/\/doi.org\/10.1016\/j.ejps.2020.105303","journal-title":"Eur J Pharmaceut Sci: off J Eur Feder Pharmaceut Sci"},{"issue":"22","key":"1579_CR39","doi-asserted-by":"publisher","first-page":"10534","DOI":"10.1111\/jcmm.16984","volume":"25","author":"C Han","year":"2021","unstructured":"Han C, Hu Q, Yu A, Jiao Q, Yang Y (2021) Mafenide derivatives inhibit neuroinflammation in Alzheimer\u2019s disease by regulating pyroptosis. J Cell Mol Med 25(22):10534\u201310542. https:\/\/doi.org\/10.1111\/jcmm.16984","journal-title":"J Cell Mol Med"},{"issue":"9","key":"1579_CR40","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00011-023-01790-4","volume":"72","author":"YH Han","year":"2023","unstructured":"Han YH, Liu XD, Jin MH, Sun HN, Kwon T (2023) Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases. Inflammat Res: off J Eur Histam Res Soc 72(9):1839\u20131859. https:\/\/doi.org\/10.1007\/s00011-023-01790-4","journal-title":"Inflammat Res: off J Eur Histam Res Soc"},{"key":"1579_CR41","unstructured":"Hardin MD, Jacobs TF (2025) Glyburide. In: StatPearls. StatPearls Publishing Copyright \u00a9 2025, StatPearls publishing LLC., Treasure Island (FL) ineligible companies. Disclosure: Tibb Jacobs declares no relevant financial relationships with ineligible companies"},{"issue":"1","key":"1579_CR42","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","volume":"9","author":"H He","year":"2018","unstructured":"He H, Jiang H, Chen Y, Ye J, Wang A, Wang C, Liu Q, Liang G, Deng X, Jiang W, Zhou R (2018) Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun 9(1):2550. https:\/\/doi.org\/10.1038\/s41467-018-04947-6","journal-title":"Nat Commun"},{"issue":"7434","key":"1579_CR43","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT (2013) NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493(7434):674\u2013678. https:\/\/doi.org\/10.1038\/nature11729","journal-title":"Nature"},{"issue":"21","key":"1579_CR44","doi-asserted-by":"publisher","first-page":"12209","DOI":"10.18632\/aging.205174","volume":"15","author":"W Hong","year":"2023","unstructured":"Hong W, Hu C, Wang C, Zhu B, Tian M, Qin H (2023) Effects of amyloid \u03b2 (A\u03b2)42 and Gasdermin D on the progression of Alzheimer\u2019s disease in vitro and in vivo through the regulation of astrocyte pyroptosis. Aging (Albany NY) 15(21):12209\u201312224. https:\/\/doi.org\/10.18632\/aging.205174","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"1579_CR45","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu JJ, Liu X, Xia S, Zhang Z, Zhang Y, Zhao J, Ruan J, Luo X, Lou X, Bai Y, Wang J, Hollingsworth LR, Magupalli VG, Zhao L, Luo HR, Kim J, Lieberman J, Wu H (2020) FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol 21(7):736\u2013745. https:\/\/doi.org\/10.1038\/s41590-020-0669-6","journal-title":"Nat Immunol"},{"key":"1579_CR46","doi-asserted-by":"publisher","first-page":"996646","DOI":"10.3389\/fnagi.2022.996646","volume":"14","author":"Y Huang","year":"2022","unstructured":"Huang Y, Li X, Luo G, Wang J, Li R, Zhou C, Wan T, Yang F (2022) Pyroptosis as a candidate therapeutic target for Alzheimer\u2019s disease. Front Aging Neurosci 14:996646. https:\/\/doi.org\/10.3389\/fnagi.2022.996646","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"1579_CR47","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.biopsych.2023.10.008","volume":"95","author":"YY Huang","year":"2024","unstructured":"Huang YY, Gan YH, Yang L, Cheng W, Yu JT (2024) Depression in Alzheimer\u2019s disease: epidemiology, mechanisms, and treatment. Biol Psychiat 95(11):992\u20131005. https:\/\/doi.org\/10.1016\/j.biopsych.2023.10.008","journal-title":"Biol Psychiat"},{"issue":"3","key":"1579_CR48","doi-asserted-by":"publisher","first-page":"C784","DOI":"10.1152\/ajpcell.00503.2023","volume":"326","author":"G Imre","year":"2024","unstructured":"Imre G (2024) Pyroptosis in health and disease. Am J Physiol Cell Physiol 326(3):C784-c794. https:\/\/doi.org\/10.1152\/ajpcell.00503.2023","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7784","key":"1579_CR49","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S, McManus RM, Tejera D, Griep A, Santarelli F, Brosseron F, Opitz S, Stunden J, Merten M, Kayed R, Golenbock DT, Blum D, Latz E, Bu\u00e9e L, Heneka MT (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575(7784):669\u2013673. https:\/\/doi.org\/10.1038\/s41586-019-1769-z","journal-title":"Nature"},{"issue":"10","key":"1579_CR50","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1111\/jnc.15788","volume":"168","author":"D Jha","year":"2024","unstructured":"Jha D, Bakker E, Kumar R (2024) Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer\u2019s disease. J Neurochem 168(10):3574\u20133598. https:\/\/doi.org\/10.1111\/jnc.15788","journal-title":"J Neurochem"},{"issue":"11","key":"1579_CR51","doi-asserted-by":"publisher","first-page":"9723","DOI":"10.1007\/s12035-024-04341-y","volume":"61","author":"J Jia","year":"2024","unstructured":"Jia J, Liu H, Sun L, Xu Y, Zeng X (2024) Thioredoxin-1 protects neurons through inhibiting NLRP1-mediated neuronal pyroptosis in models of Alzheimer\u2019s disease. Mol Neurobiol 61(11):9723\u20139734. https:\/\/doi.org\/10.1007\/s12035-024-04341-y","journal-title":"Mol Neurobiol"},{"issue":"5","key":"1579_CR52","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/cns.13086","volume":"25","author":"X Jin","year":"2019","unstructured":"Jin X, Liu MY, Zhang DF, Zhong X, Du K, Qian P, Yao WF, Gao H, Wei MJ (2019) Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4\/NF-\u03baB signaling pathway. CNS Neurosci Ther 25(5):575\u2013590. https:\/\/doi.org\/10.1111\/cns.13086","journal-title":"CNS Neurosci Ther"},{"key":"1579_CR53","doi-asserted-by":"publisher","first-page":"173416","DOI":"10.1016\/j.ejphar.2020.173416","volume":"884","author":"YJ Ju","year":"2020","unstructured":"Ju YJ, Kim N, Gee MS, Jeon SH, Lee D, Do J, Ryu JS, Lee JK (2020) Glibenclamide modulates microglial function and attenuates A\u03b2 deposition in 5XFAD mice. Eur J Pharmacol 884:173416. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173416","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"1579_CR54","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","volume":"187","author":"M Kitazawa","year":"2011","unstructured":"Kitazawa M, Cheng D, Tsukamoto MR, Koike MA, Wes PD, Vasilevko V, Cribbs DH, LaFerla FM (2011) Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal \u03b2-catenin pathway function in an Alzheimer\u2019s disease model. J Immunol 187(12):6539\u20136549. https:\/\/doi.org\/10.4049\/jimmunol.1100620","journal-title":"J Immunol"},{"key":"1579_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ahj.2020.07.004","volume":"228","author":"AL Klein","year":"2020","unstructured":"Klein AL, Imazio M, Brucato A, Cremer P, LeWinter M, Abbate A, Lin D, Martini A, Beutler A, Chang S, Fang F, Gervais A, Perrin R, Paolini JF (2020) RHAPSODY: rationale for and design of a pivotal phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1\u03b1 and interleukin-1\u03b2 trap, in patients with recurrent pericarditis. Am Heart J 228:81\u201390. https:\/\/doi.org\/10.1016\/j.ahj.2020.07.004","journal-title":"Am Heart J"},{"issue":"5","key":"1579_CR56","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/s2665-9913(20)30065-5","volume":"2","author":"V Kl\u00fcck","year":"2020","unstructured":"Kl\u00fcck V, Jansen T, Janssen M, Comarniceanu A, Efd\u00e9 M, Tengesdal IW, Schraa K, Cleophas MCP, Scribner CL, Skouras DB, Marchetti C, Dinarello CA, Joosten LAB (2020) Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol 2(5):e270\u2013e280. https:\/\/doi.org\/10.1016\/s2665-9913(20)30065-5","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"1579_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40035-022-00296-z","volume":"11","author":"TO Klyucherev","year":"2022","unstructured":"Klyucherev TO, Olszewski P, Shalimova AA, Chubarev VN, Tarasov VV, Attwood MM, Syv\u00e4nen S, Schi\u00f6th HB (2022) Advances in the development of new biomarkers for Alzheimer\u2019s disease. Translat Neurodegen 11(1):25. https:\/\/doi.org\/10.1186\/s40035-022-00296-z","journal-title":"Translat Neurodegen"},{"issue":"1","key":"1579_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11481-024-10101-5","volume":"19","author":"T Kodi","year":"2024","unstructured":"Kodi T, Sankhe R, Gopinathan A, Nandakumar K, Kishore A (2024) New insights on NLRP3 inflammasome: mechanisms of activation, inhibition, and epigenetic regulation. J Neuroimmune Pharmacol: off J S NeuroImmune Pharmacol 19(1):7. https:\/\/doi.org\/10.1007\/s11481-024-10101-5","journal-title":"J Neuroimmune Pharmacol: off J S NeuroImmune Pharmacol"},{"key":"1579_CR59","doi-asserted-by":"publisher","first-page":"147220","DOI":"10.1016\/j.brainres.2020.147220","volume":"1752","author":"YK Komleva","year":"2021","unstructured":"Komleva YK, Lopatina OL, Gorina IV, Shuvaev AN, Chernykh A, Potapenko IV, Salmina AB (2021) NLRP3 deficiency-induced hippocampal dysfunction and anxiety-like behavior in mice. Brain Res 1752:147220. https:\/\/doi.org\/10.1016\/j.brainres.2020.147220","journal-title":"Brain Res"},{"issue":"9","key":"1579_CR60","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.tcb.2017.05.005","volume":"27","author":"SB Kovacs","year":"2017","unstructured":"Kovacs SB, Miao EA (2017) Gasdermins: effectors of pyroptosis. Trends Cell Biol 27(9):673\u2013684. https:\/\/doi.org\/10.1016\/j.tcb.2017.05.005","journal-title":"Trends Cell Biol"},{"issue":"5","key":"1579_CR61","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1369\/jhc.6A7101.2006","volume":"55","author":"JA Kummer","year":"2007","unstructured":"Kummer JA, Broekhuizen R, Everett H, Agostini L, Kuijk L, Martinon F, van Bruggen R, Tschopp J (2007) Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem: off J Histochem Soc 55(5):443\u2013452. https:\/\/doi.org\/10.1369\/jhc.6A7101.2006","journal-title":"J Histochem Cytochem: off J Histochem Soc"},{"issue":"1","key":"1579_CR62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12974-019-1471-y","volume":"16","author":"R Kuwar","year":"2019","unstructured":"Kuwar R, Rolfe A, Di L, Xu H, He L, Jiang Y, Zhang S, Sun D (2019) A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury. J Neuroinflam 16(1):81. https:\/\/doi.org\/10.1186\/s12974-019-1471-y","journal-title":"J Neuroinflam"},{"issue":"4","key":"1579_CR63","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3233\/jad-210400","volume":"82","author":"R Kuwar","year":"2021","unstructured":"Kuwar R, Rolfe A, Di L, Blevins H, Xu Y, Sun X, Bloom GS, Zhang S, Sun D (2021) A novel inhibitor targeting NLRP3 inflammasome reduces neuropathology and improves cognitive function in Alzheimer\u2019s disease transgenic mice. J Alzheimer\u2019s Dis: JAD 82(4):1769\u20131783. https:\/\/doi.org\/10.3233\/jad-210400","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"1","key":"1579_CR64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.200903124","volume":"187","author":"M Lamkanfi","year":"2009","unstructured":"Lamkanfi M, Mueller JL, Vitari AC, Misaghi S, Fedorova A, Deshayes K, Lee WP, Hoffman HM, Dixit VM (2009) Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome. J Cell Biol 187(1):61\u201370. https:\/\/doi.org\/10.1083\/jcb.200903124","journal-title":"J Cell Biol"},{"issue":"11","key":"1579_CR65","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1007\/s00221-020-05916-6","volume":"238","author":"J Li","year":"2020","unstructured":"Li J, Zhuang L, Luo X, Liang J, Sun E, He Y (2020a) Protection of MCC950 against Alzheimer\u2019s disease via inhibiting neuronal pyroptosis in SAMP8 mice. Exp Brain Res 238(11):2603\u20132614. https:\/\/doi.org\/10.1007\/s00221-020-05916-6","journal-title":"Exp Brain Res"},{"key":"1579_CR66","doi-asserted-by":"publisher","first-page":"109618","DOI":"10.1016\/j.biopha.2019.109618","volume":"121","author":"Y Li","year":"2020","unstructured":"Li Y, Xu P, Shan J, Sun W, Ji X, Chi T, Liu P, Zou L (2020b) Interaction between hyperphosphorylated tau and pyroptosis in forskolin and streptozotocin induced AD models. Biomed Pharmacother 121:109618. https:\/\/doi.org\/10.1016\/j.biopha.2019.109618","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1579_CR67","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12974-023-02791-0","volume":"20","author":"JM Li","year":"2023","unstructured":"Li JM, Hu T, Zhou XN, Zhang T, Guo JH, Wang MY, Wu YL, Su WJ, Jiang CL (2023a) The involvement of NLRP3 inflammasome in CUMS-induced AD-like pathological changes and related cognitive decline in mice. J Neuroinflam 20(1):112. https:\/\/doi.org\/10.1186\/s12974-023-02791-0","journal-title":"J Neuroinflam"},{"issue":"1","key":"1579_CR68","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12993-023-00209-8","volume":"19","author":"X Li","year":"2023","unstructured":"Li X, Zhang H, Yang L, Dong X, Han Y, Su Y, Li W, Li W (2023b) Inhibition of NLRP1 inflammasome improves autophagy dysfunction and A\u03b2 disposition in APP\/PS1 mice. Behavioral Brain Funct: BBF 19(1):7. https:\/\/doi.org\/10.1186\/s12993-023-00209-8","journal-title":"Behavioral Brain Funct: BBF"},{"key":"1579_CR69","doi-asserted-by":"publisher","first-page":"115097","DOI":"10.1016\/j.expneurol.2024.115097","volume":"385","author":"YB Liang","year":"2025","unstructured":"Liang YB, Luo RX, Lu Z, Mao Y, Song PP, Li QW, Peng ZQ, Zhang YS (2025) VX-765 attenuates secondary damage and \u03b2-amyloid accumulation in ipsilateral thalamus after experimental stroke in rats. Exp Neurol 385:115097. https:\/\/doi.org\/10.1016\/j.expneurol.2024.115097","journal-title":"Exp Neurol"},{"issue":"6","key":"1579_CR70","doi-asserted-by":"publisher","first-page":"e40027","DOI":"10.1371\/journal.pone.0040027","volume":"7","author":"CA Libeu","year":"2012","unstructured":"Libeu CA, Descamps O, Zhang Q, John V, Bredesen DE (2012) Altering APP proteolysis: increasing sAPPalpha production by targeting dimerization of the APP ectodomain. PLoS ONE 7(6):e40027. https:\/\/doi.org\/10.1371\/journal.pone.0040027","journal-title":"PLoS ONE"},{"issue":"7610","key":"1579_CR71","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature18629","volume":"535","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, Lieberman J (2016) Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535(7610):153\u2013158. https:\/\/doi.org\/10.1038\/nature18629","journal-title":"Nature"},{"issue":"1","key":"1579_CR72","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1089\/ars.2015.6615","volume":"26","author":"X Liu","year":"2017","unstructured":"Liu X, Zhang X, Ding Y, Zhou W, Tao L, Lu P, Wang Y, Hu R (2017) Nuclear factor E2-related factor-2 negatively regulates NLRP3 inflammasome activity by inhibiting reactive oxygen species-induced NLRP3 priming. Antioxid Redox Signal 26(1):28\u201343. https:\/\/doi.org\/10.1089\/ars.2015.6615","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"1579_CR73","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s12640-022-00554-y","volume":"40","author":"X Liu","year":"2022","unstructured":"Liu X, Song W, Yu Y, Su J, Shi X, Yang X, Wang H, Liu P, Zou L (2022) Inhibition of NLRP1-dependent pyroptosis prevents glycogen synthase kinase-3\u03b2 overactivation-induced hyperphosphorylated Tau in rats. Neurotox Res 40(5):1163\u20131173. https:\/\/doi.org\/10.1007\/s12640-022-00554-y","journal-title":"Neurotox Res"},{"issue":"50","key":"1579_CR74","doi-asserted-by":"publisher","first-page":"32145","DOI":"10.1073\/pnas.2009680117","volume":"117","author":"N Lonnemann","year":"2020","unstructured":"Lonnemann N, Hosseini S, Marchetti C, Skouras DB, Stefanoni D, D\u2019Alessandro A, Dinarello CA, Korte M (2020) The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 117(50):32145\u201332154. https:\/\/doi.org\/10.1073\/pnas.2009680117","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1579_CR75","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1002\/jcp.29268","volume":"235","author":"F Lu","year":"2020","unstructured":"Lu F, Lan Z, Xin Z, He C, Guo Z, Xia X, Hu T (2020) Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases. J Cell Physiol 235(4):3207\u20133221. https:\/\/doi.org\/10.1002\/jcp.29268","journal-title":"J Cell Physiol"},{"issue":"6","key":"1579_CR76","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/jnc.14945","volume":"155","author":"A Lu\u010di\u016bnait\u0117","year":"2020","unstructured":"Lu\u010di\u016bnait\u0117 A, McManus RM, Jankunec M, R\u00e1cz I, Dansokho C, Dalg\u0117dien\u0117 I, Schwartz S, Brosseron F, Heneka MT (2020) Soluble A\u03b2 oligomers and protofibrils induce NLRP3 inflammasome activation in microglia. J Neurochem 155(6):650\u2013661. https:\/\/doi.org\/10.1111\/jnc.14945","journal-title":"J Neurochem"},{"issue":"5","key":"1579_CR77","first-page":"568","volume":"13","author":"SH MacKenzie","year":"2010","unstructured":"MacKenzie SH, Schipper JL, Clark AC (2010) The potential for caspases in drug discovery. Curr Opin Drug Discov Devel 13(5):568\u2013576","journal-title":"Curr Opin Drug Discov Devel"},{"key":"1579_CR78","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.omtn.2019.10.002","volume":"18","author":"H Mai","year":"2019","unstructured":"Mai H, Fan W, Wang Y, Cai Y, Li X, Chen F, Chen X, Yang J, Tang P, Chen H, Zou T, Hong T, Wan C, Zhao B, Cui L (2019) Intranasal administration of miR-146a agomir rescued the pathological process and cognitive impairment in an AD mouse model. Mol Ther Nucleic Acids 18:681\u2013695. https:\/\/doi.org\/10.1016\/j.omtn.2019.10.002","journal-title":"Mol Ther Nucleic Acids"},{"key":"1579_CR79","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.biochi.2023.03.007","volume":"211","author":"S Malik","year":"2023","unstructured":"Malik S, Siddiqi MK, Naseem N, Nabi F, Masroor A, Majid N, Hashmi A, Khan RH (2023) Biophysical insight into the anti-fibrillation potential of Glyburide for its possible implication in therapeutic intervention of amyloid associated diseases. Biochimie 211:110\u2013121. https:\/\/doi.org\/10.1016\/j.biochi.2023.03.007","journal-title":"Biochimie"},{"issue":"1","key":"1579_CR80","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12534","volume":"277","author":"SM Man","year":"2017","unstructured":"Man SM, Karki R, Kanneganti TD (2017) Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev 277(1):61\u201375. https:\/\/doi.org\/10.1111\/imr.12534","journal-title":"Immunol Rev"},{"issue":"8","key":"1579_CR81","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E (2018) Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discovery 17(8):588\u2013606. https:\/\/doi.org\/10.1038\/nrd.2018.97","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"1579_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/fjc.0000000000000247","volume":"66","author":"C Marchetti","year":"2015","unstructured":"Marchetti C, Toldo S, Chojnacki J, Mezzaroma E, Liu K, Salloum FN, Nordio A, Carbone S, Mauro AG, Das A, Zalavadia AA, Halquist MS, Federici M, Van Tassell BW, Zhang S, Abbate A (2015) Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and nonischemic injury in the mouse. J Cardiovasc Pharmacol 66(1):1\u20138. https:\/\/doi.org\/10.1097\/fjc.0000000000000247","journal-title":"J Cardiovasc Pharmacol"},{"issue":"7","key":"1579_CR83","doi-asserted-by":"publisher","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","volume":"115","author":"C Marchetti","year":"2018","unstructured":"Marchetti C, Swartzwelter B, Gamboni F, Neff CP, Richter K, Azam T, Carta S, Tengesdal I, Nemkov T, D\u2019Alessandro A, Henry C, Jones GS, Goodrich SA, St Laurent JP, Jones TM, Scribner CL, Barrow RB, Altman RD, Skouras DB, Gattorno M, Grau V, Janciauskiene S, Rubartelli A, Joosten LAB, Dinarello CA (2018a) OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proc Natl Acad Sci USA 115(7):E1530-e1539. https:\/\/doi.org\/10.1073\/pnas.1716095115","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1579_CR84","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13075-018-1664-2","volume":"20","author":"C Marchetti","year":"2018","unstructured":"Marchetti C, Swartzwelter B, Koenders MI, Azam T, Tengesdal IW, Powers N, de Graaf DM, Dinarello CA, Joosten LAB (2018b) NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis. Arthritis Res Ther 20(1):169. https:\/\/doi.org\/10.1186\/s13075-018-1664-2","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1579_CR85","doi-asserted-by":"publisher","first-page":"e2101166","DOI":"10.1002\/adbi.202101166","volume":"6","author":"RM McManus","year":"2022","unstructured":"McManus RM (2022) The role of immunity in Alzheimer\u2019s disease. Adv Biol 6(5):e2101166. https:\/\/doi.org\/10.1002\/adbi.202101166","journal-title":"Adv Biol"},{"issue":"1\u20132","key":"1579_CR86","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jneuroim.2005.03.013","volume":"164","author":"S Meeuwsen","year":"2005","unstructured":"Meeuwsen S, Persoon-Deen C, Bsibsi M, Bajramovic JJ, Ravid R, De Bolle L, van Noort JM (2005) Modulation of the cytokine network in human adult astrocytes by human herpesvirus-6A. J Neuroimmunol 164(1\u20132):37\u201347","journal-title":"J Neuroimmunol"},{"issue":"16","key":"1579_CR87","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.3390\/molecules26165068","volume":"26","author":"RA Mohamed","year":"2021","unstructured":"Mohamed RA, Abdallah DM, El-Brairy AI, Ahmed KA, El-Abhar HS (2021) Palonosetron\/Methyllycaconitine deactivate hippocampal microglia 1, inflammasome assembly and pyroptosis to enhance cognition in a novel model of neuroinflammation. Molecules 26(16):5068. https:\/\/doi.org\/10.3390\/molecules26165068","journal-title":"Molecules"},{"key":"1579_CR88","doi-asserted-by":"publisher","first-page":"115522","DOI":"10.1016\/j.bcp.2023.115522","volume":"211","author":"AR Monteiro","year":"2023","unstructured":"Monteiro AR, Barbosa DJ, Remi\u00e3o F, Silva R (2023) Alzheimer\u2019s disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs. Biochem Pharmacol 211:115522. https:\/\/doi.org\/10.1016\/j.bcp.2023.115522","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1579_CR89","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00401-022-02528-y","volume":"145","author":"S Moonen","year":"2023","unstructured":"Moonen S, Koper MJ, Van Schoor E, Schaeverbeke JM, Vandenberghe R, von Arnim CAF, Tousseyn T, De Strooper B, Thal DR (2023) Pyroptosis in Alzheimer\u2019s disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol 145(2):175\u2013195. https:\/\/doi.org\/10.1007\/s00401-022-02528-y","journal-title":"Acta Neuropathol"},{"issue":"7","key":"1579_CR90","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","volume":"28","author":"D Moujalled","year":"2021","unstructured":"Moujalled D, Strasser A, Liddell JR (2021) Molecular mechanisms of cell death in neurological diseases. Cell Death Differ 28(7):2029\u20132044. https:\/\/doi.org\/10.1038\/s41418-021-00814-y","journal-title":"Cell Death Differ"},{"issue":"5","key":"1579_CR91","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"AR Mridha","year":"2017","unstructured":"Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM, Haczeyni F, Teoh NC, Savard C, Ioannou GN, Masters SL, Schroder K, Cooper MA, Feldstein AE, Farrell GC (2017) NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol 66(5):1037\u20131046. https:\/\/doi.org\/10.1016\/j.jhep.2017.01.022","journal-title":"J Hepatol"},{"key":"1579_CR92","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s41232-018-0085-6","volume":"38","author":"A Nakanishi","year":"2018","unstructured":"Nakanishi A, Kaneko N, Takeda H, Sawasaki T, Morikawa S, Zhou W, Kurata M, Yamamoto T, Akbar SMF, Zako T, Masumoto J (2018) Amyloid \u03b2 directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell-free system. Inflamm Regen 38:27. https:\/\/doi.org\/10.1186\/s41232-018-0085-6","journal-title":"Inflamm Regen"},{"issue":"8","key":"1579_CR93","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/s1474-4422(22)00168-5","volume":"21","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, van der Kant R, Hansson O (2022) Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials. Lancet Neurol 21(8):726\u2013734. https:\/\/doi.org\/10.1016\/s1474-4422(22)00168-5","journal-title":"Lancet Neurol"},{"key":"1579_CR94","doi-asserted-by":"publisher","first-page":"1459134","DOI":"10.3389\/fnagi.2024.1459134","volume":"16","author":"I Paesmans","year":"2024","unstructured":"Paesmans I, Van Kolen K, Vandermeeren M, Shih PY, Wuyts D, Boone F, Garcia Sanchez S, Grauwen K, Van Hauwermeiren F, Van Opdenbosch N, Lamkanfi M, van Loo G, Bottelbergs A (2024) NLRP3 inflammasome activation and pyroptosis are dispensable for tau pathology. Front Aging Neurosci 16:1459134. https:\/\/doi.org\/10.3389\/fnagi.2024.1459134","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"1579_CR95","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.3390\/cells10071652","volume":"10","author":"C Panda","year":"2021","unstructured":"Panda C, Voelz C, Habib P, Mevissen C, Pufe T, Beyer C, Gupta S, Slowik A (2021) Aggregated Tau-PHF6 (VQIVYK) potentiates NLRP3 inflammasome expression and autophagy in human microglial cells. Cells 10(7):1652. https:\/\/doi.org\/10.3390\/cells10071652","journal-title":"Cells"},{"issue":"1","key":"1579_CR96","doi-asserted-by":"publisher","first-page":"e13406","DOI":"10.1111\/imr.13406","volume":"329","author":"A Pandey","year":"2025","unstructured":"Pandey A, Li Z, Gautam M, Ghosh A, Man SM (2025) Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis. Immunol Rev 329(1):e13406. https:\/\/doi.org\/10.1111\/imr.13406","journal-title":"Immunol Rev"},{"issue":"2","key":"1579_CR97","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JAD-180802","volume":"68","author":"G Paroni","year":"2019","unstructured":"Paroni G, Bisceglia P, Seripa D (2019) Understanding the amyloid hypothesis in alzheimer\u2019s disease. J Alzheimer\u2019s Dis: JAD 68(2):493\u2013510. https:\/\/doi.org\/10.3233\/JAD-180802","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"1","key":"1579_CR98","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0022-3565(24)29317-4","volume":"299","author":"DG Perregaux","year":"2001","unstructured":"Perregaux DG, McNiff P, Laliberte R, Hawryluk N, Peurano H, Stam E, Eggler J, Griffiths R, Dombroski MA, Gabel CA (2001) Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors. J Pharmacol Exp Ther 299(1):187\u2013197","journal-title":"J Pharmacol Exp Ther"},{"key":"1579_CR99","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.nbd.2018.02.016","volume":"114","author":"Y Qi","year":"2018","unstructured":"Qi Y, Klyubin I, Cuello AC, Rowan MJ (2018) NLRP3-dependent synaptic plasticity deficit in an Alzheimer\u2019s disease amyloidosis model in vivo. Neurobiol Dis 114:24\u201330. https:\/\/doi.org\/10.1016\/j.nbd.2018.02.016","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1579_CR100","doi-asserted-by":"publisher","first-page":"95","DOI":"10.14283\/jpad.2023.3","volume":"10","author":"Z Qiu","year":"2023","unstructured":"Qiu Z, Zhang H, Xia M, Gu J, Guo K, Wang H, Miao C (2023) Programmed death of microglia in Alzheimer\u2019s disease: autophagy, ferroptosis, and pyroptosis. J Prevent Alzheimer\u2019s Dis 10(1):95\u2013103. https:\/\/doi.org\/10.14283\/jpad.2023.3","journal-title":"J Prevent Alzheimer\u2019s Dis"},{"key":"1579_CR101","doi-asserted-by":"publisher","first-page":"1471005","DOI":"10.3389\/fncel.2024.1471005","volume":"18","author":"W Quan","year":"2024","unstructured":"Quan W, Decker Y, Luo Q, Chemla A, Chang HF, Li D, Fassbender K, Liu Y (2024) Deficiency of NLRP3 protects cerebral pericytes and attenuates Alzheimer\u2019s pathology in tau-transgenic mice. Front Cell Neurosci 18:1471005. https:\/\/doi.org\/10.3389\/fncel.2024.1471005","journal-title":"Front Cell Neurosci"},{"key":"1579_CR102","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semcdb.2018.01.002","volume":"82","author":"MLG Ramirez","year":"2018","unstructured":"Ramirez MLG, Salvesen GS (2018) A primer on caspase mechanisms. Semin Cell Dev Biol 82:79\u201385. https:\/\/doi.org\/10.1016\/j.semcdb.2018.01.002","journal-title":"Semin Cell Dev Biol"},{"issue":"9","key":"1579_CR103","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.7150\/thno.71086","volume":"12","author":"Z Rao","year":"2022","unstructured":"Rao Z, Zhu Y, Yang P, Chen Z, Xia Y, Qiao C, Liu W, Deng H, Li J, Ning P, Wang Z (2022) Pyroptosis in inflammatory diseases and cancer. Theranostics 12(9):4310\u20134329. https:\/\/doi.org\/10.7150\/thno.71086","journal-title":"Theranostics"},{"issue":"1","key":"1579_CR104","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/s41598-018-19577-7","volume":"8","author":"S Reinhardt","year":"2018","unstructured":"Reinhardt S, Stoye N, Luderer M, Kiefer F, Schmitt U, Lieb K, Endres K (2018) Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer\u2019s disease hallmarks. Sci Rep 8(1):1329. https:\/\/doi.org\/10.1038\/s41598-018-19577-7","journal-title":"Sci Rep"},{"issue":"2","key":"1579_CR105","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s13311-018-00698-w","volume":"16","author":"QG Ren","year":"2019","unstructured":"Ren QG, Gong WG, Zhou H, Shu H, Wang YJ, Zhang ZJ (2019) Spatial training ameliorates long-term Alzheimer\u2019s disease-like pathological deficits by reducing NLRP3 inflammasomes in PR5 Mice. Neurotherapeut J Am Soc Experiment NeuroTherapeut 16(2):450\u2013464. https:\/\/doi.org\/10.1007\/s13311-018-00698-w","journal-title":"Neurotherapeut J Am Soc Experiment NeuroTherapeut"},{"issue":"12","key":"1579_CR106","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377(12):1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMoa1707914","journal-title":"N Engl J Med"},{"key":"1579_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010107","author":"AA Rostagno","year":"2022","unstructured":"Rostagno AA (2022) Pathogenesis of Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24010107","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1579_CR108","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1002\/eji.201545772","volume":"45","author":"S R\u00fchl","year":"2015","unstructured":"R\u00fchl S, Broz P (2015) Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux. Eur J Immunol 45(10):2927\u20132936. https:\/\/doi.org\/10.1002\/eji.201545772","journal-title":"Eur J Immunol"},{"key":"1579_CR109","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-016-0088-1","volume":"11","author":"M Saresella","year":"2016","unstructured":"Saresella M, La Rosa F, Piancone F, Zoppis M, Marventano I, Calabrese E, Rainone V, Nemni R, Mancuso R, Clerici M (2016) The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer\u2019s disease. Mol Neurodegener 11:23. https:\/\/doi.org\/10.1186\/s13024-016-0088-1","journal-title":"Mol Neurodegener"},{"issue":"16","key":"1579_CR110","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.15252\/embj.201694696","volume":"35","author":"L Sborgi","year":"2016","unstructured":"Sborgi L, R\u00fchl S, Mulvihill E, Pipercevic J, Heilig R, Stahlberg H, Farady CJ, M\u00fcller DJ, Broz P, Hiller S (2016) GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J 35(16):1766\u20131778. https:\/\/doi.org\/10.15252\/embj.201694696","journal-title":"EMBO J"},{"issue":"4","key":"1579_CR111","doi-asserted-by":"publisher","first-page":"e02063","DOI":"10.1002\/brb3.2063","volume":"11","author":"H Shen","year":"2021","unstructured":"Shen H, Han C, Yang Y, Guo L, Sheng Y, Wang J, Li W, Zhai L, Wang G, Guan Q (2021) Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer\u2019s disease. Brain Behavior 11(4):e02063. https:\/\/doi.org\/10.1002\/brb3.2063","journal-title":"Brain Behavior"},{"issue":"7521","key":"1579_CR112","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature13683","volume":"514","author":"J Shi","year":"2014","unstructured":"Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, Hu L, Shao F (2014) Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 514(7521):187\u2013192. https:\/\/doi.org\/10.1038\/nature13683","journal-title":"Nature"},{"issue":"7575","key":"1579_CR113","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526(7575):660\u2013665. https:\/\/doi.org\/10.1038\/nature15514","journal-title":"Nature"},{"issue":"10","key":"1579_CR114","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.tins.2023.07.009","volume":"46","author":"J Singh","year":"2023","unstructured":"Singh J, Habean ML, Panicker N (2023) Inflammasome assembly in neurodegenerative diseases. Trends Neurosci 46(10):814\u2013831. https:\/\/doi.org\/10.1016\/j.tins.2023.07.009","journal-title":"Trends Neurosci"},{"key":"1579_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/cells11142223","author":"E \u0160pani\u0107","year":"2022","unstructured":"\u0160pani\u0107 E, Langer Horvat L, Ili\u0107 K, Hof PR, \u0160imi\u0107 G (2022) NLRP1 inflammasome activation in the hippocampal formation in Alzheimer\u2019s disease: correlation with neuropathological changes and unbiasedly estimated neuronal loss. Cells. https:\/\/doi.org\/10.3390\/cells11142223","journal-title":"Cells"},{"issue":"4","key":"1579_CR116","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","volume":"137","author":"IC Stancu","year":"2019","unstructured":"Stancu IC, Cremers N, Vanrusselt H, Couturier J, Vanoosthuyse A, Kessels S, Lodder C, Br\u00f4ne B, Huaux F, Octave JN, Terwel D, Dewachter I (2019) Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo. Acta Neuropathol 137(4):599\u2013617. https:\/\/doi.org\/10.1007\/s00401-018-01957-y","journal-title":"Acta Neuropathol"},{"issue":"1\u20132","key":"1579_CR117","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X, Wang X (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148(1\u20132):213\u2013227. https:\/\/doi.org\/10.1016\/j.cell.2011.11.031","journal-title":"Cell"},{"issue":"7\u20138","key":"1579_CR118","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1007\/s10495-024-01976-z","volume":"29","author":"E Svandova","year":"2024","unstructured":"Svandova E, Vesela B, Janeckova E, Chai Y, Matalova E (2024) Exploring caspase functions in mouse models. Apoptosis: an Int J Program Cell Death 29(7\u20138):938\u2013966. https:\/\/doi.org\/10.1007\/s10495-024-01976-z","journal-title":"Apoptosis: an Int J Program Cell Death"},{"issue":"8","key":"1579_CR119","doi-asserted-by":"publisher","first-page":"e1382","DOI":"10.1038\/cddis.2014.348","volume":"5","author":"MS Tan","year":"2014","unstructured":"Tan MS, Tan L, Jiang T, Zhu XC, Wang HF, Jia CD, Yu JT (2014) Amyloid-\u03b2 induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer\u2019s disease. Cell Death Dis 5(8):e1382. https:\/\/doi.org\/10.1038\/cddis.2014.348","journal-title":"Cell Death Dis"},{"issue":"17","key":"1579_CR120","doi-asserted-by":"publisher","first-page":"e101064","DOI":"10.15252\/embj.2018101064","volume":"38","author":"D Tejera","year":"2019","unstructured":"Tejera D, Mercan D, Sanchez-Caro JM, Hanan M, Greenberg D, Soreq H, Latz E, Golenbock D, Heneka MT (2019) Systemic inflammation impairs microglial A\u03b2 clearance through NLRP3 inflammasome. EMBO J 38(17):e101064. https:\/\/doi.org\/10.15252\/embj.2018101064","journal-title":"EMBO J"},{"issue":"3","key":"1579_CR121","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1211\/0022357022755","volume":"56","author":"N Teramoto","year":"2004","unstructured":"Teramoto N, Zhu HL, Ito Y (2004) Blocking actions of glibenclamide on ATP-sensitive K+ channels in pig urethral myocytes. J Pharm Pharmacol 56(3):395\u2013399. https:\/\/doi.org\/10.1211\/0022357022755","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"1579_CR122","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/bf00232907","volume":"129","author":"F Th\u00e9venod","year":"1992","unstructured":"Th\u00e9venod F, Chathadi KV, Jiang B, Hopfer U (1992) ATP-sensitive K+ conductance in pancreatic zymogen granules: block by glyburide and activation by diazoxide. J Membr Biol 129(3):253\u2013266. https:\/\/doi.org\/10.1007\/bf00232907","journal-title":"J Membr Biol"},{"key":"1579_CR123","doi-asserted-by":"publisher","first-page":"801422","DOI":"10.3389\/fcell.2021.801422","volume":"9","author":"D Tian","year":"2021","unstructured":"Tian D, Xing Y, Gao W, Zhang H, Song Y, Tian Y, Dai Z (2021) Sevoflurane aggravates the progress of Alzheimer\u2019s disease through NLRP3\/Caspase-1\/Gasdermin D pathway. Front Cell Development Biol 9:801422. https:\/\/doi.org\/10.3389\/fcell.2021.801422","journal-title":"Front Cell Development Biol"},{"issue":"4","key":"1579_CR124","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/fjc.0000000000000658","volume":"73","author":"S Toldo","year":"2019","unstructured":"Toldo S, Mauro AG, Cutter Z, Van Tassell BW, Mezzaroma E, Del Buono MG, Prestamburgo A, Potere N, Abbate A (2019) The NLRP3 inflammasome inhibitor, OLT1177 (Dapansutrile), reduces infarct size and preserves contractile function after ischemia reperfusion injury in the mouse. J Cardiovasc Pharmacol 73(4):215\u2013222. https:\/\/doi.org\/10.1097\/fjc.0000000000000658","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"1579_CR125","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/gps.3973","volume":"29","author":"KC Torres","year":"2014","unstructured":"Torres KC, Lima GS, Fiamoncini CM, Rezende VB, Pereira PA, Bicalho MA, Moraes EN, Romano-Silva MA (2014) Increased frequency of cluster of differentiation 14 (CD14+) monocytes expressing interleukin 1 beta (IL-1\u03b2) in Alzheimer\u2019s disease patients and intermediate levels in late-onset depression patients. Int J Geriatr Psychiatry 29(2):137\u2013143. https:\/\/doi.org\/10.1002\/gps.3973","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"1579_CR126","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"issue":"7605","key":"1579_CR127","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/nature17649","volume":"534","author":"L Vande Walle","year":"2016","unstructured":"Vande Walle L, Jim\u00e9nez Fern\u00e1ndez D, Demon D, Van Laethem N, Van Hauwermeiren F, Van Gorp H, Van Opdenbosch N, Kayagaki N, Lamkanfi M (2016) Does caspase-12 suppress inflammasome activation? Nature 534(7605):E1-4. https:\/\/doi.org\/10.1038\/nature17649","journal-title":"Nature"},{"issue":"3","key":"1579_CR128","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2217\/nmt-2015-0009","volume":"6","author":"AE Villarreal","year":"2016","unstructured":"Villarreal AE, O\u2019Bryant SE, Edwards M, Grajales S, Britton GB (2016) Serum-based protein profiles of Alzheimer\u2019s disease and mild cognitive impairment in elderly Hispanics. Neurodegenerat Dis Manag 6(3):203\u2013213. https:\/\/doi.org\/10.2217\/nmt-2015-0009","journal-title":"Neurodegenerat Dis Manag"},{"issue":"2","key":"1579_CR129","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/13543784.2023.2178414","volume":"32","author":"GE Vitek","year":"2023","unstructured":"Vitek GE, Decourt B, Sabbagh MN (2023) Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease. Expert Opin Investig Drugs 32(2):89\u201394. https:\/\/doi.org\/10.1080\/13543784.2023.2178414","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"1579_CR130","doi-asserted-by":"publisher","first-page":"e13142","DOI":"10.1111\/bpa.13142","volume":"33","author":"RT Vontell","year":"2023","unstructured":"Vontell RT, de Rivero Vaccari JP, Sun X, Gultekin SH, Bramlett HM, Dietrich WD, Keane RW (2023) Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer\u2019s disease. Brain Pathol 33(4):e13142. https:\/\/doi.org\/10.1111\/bpa.13142","journal-title":"Brain Pathol"},{"key":"1579_CR131","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1016\/j.csbj.2021.07.038","volume":"19","author":"Y Wang","year":"2021","unstructured":"Wang Y, Kanneganti TD (2021) From pyroptosis, apoptosis and necroptosis to PANoptosis: a mechanistic compendium of programmed cell death pathways. Comput Struct Biotechnol J 19:4641\u20134657. https:\/\/doi.org\/10.1016\/j.csbj.2021.07.038","journal-title":"Comput Struct Biotechnol J"},{"issue":"3","key":"1579_CR132","doi-asserted-by":"publisher","first-page":"e0151397","DOI":"10.1371\/journal.pone.0151397","volume":"11","author":"S Wang","year":"2016","unstructured":"Wang S, Yu L, Yang H, Li C, Hui Z, Xu Y, Zhu X (2016) Oridonin attenuates synaptic loss and cognitive deficits in an A\u03b21-42-induced mouse model of Alzheimer\u2019s disease. PLoS ONE 11(3):e0151397. https:\/\/doi.org\/10.1371\/journal.pone.0151397","journal-title":"PLoS ONE"},{"issue":"3","key":"1579_CR133","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1159\/000481753","volume":"43","author":"HM Wang","year":"2017","unstructured":"Wang HM, Zhang T, Huang JK, Xiang JY, Chen JJ, Fu JL, Zhao YW (2017) Edaravone attenuates the proinflammatory response in Amyloid-\u03b2-Treated microglia by inhibiting NLRP3 inflammasome-mediated IL-1\u03b2 secretion. Cell Physiol Biochem: Int J Experiment Cell Physiol Biochem Pharmacol 43(3):1113\u20131125. https:\/\/doi.org\/10.1159\/000481753","journal-title":"Cell Physiol Biochem: Int J Experiment Cell Physiol Biochem Pharmacol"},{"issue":"1","key":"1579_CR134","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/imcb.12301","volume":"98","author":"A Webers","year":"2020","unstructured":"Webers A, Heneka MT, Gleeson PA (2020) The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer\u2019s disease. Immunol Cell Biol 98(1):28\u201341. https:\/\/doi.org\/10.1111\/imcb.12301","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"1579_CR135","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/bpa.12478","volume":"27","author":"CS White","year":"2017","unstructured":"White CS, Lawrence CB, Brough D, Rivers-Auty J (2017) Inflammasomes as therapeutic targets for Alzheimer\u2019s disease. Brain Pathol 27(2):223\u2013234. https:\/\/doi.org\/10.1111\/bpa.12478","journal-title":"Brain Pathol"},{"issue":"1","key":"1579_CR136","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/fjc.0000000000000931","volume":"77","author":"GF Wohlford","year":"2020","unstructured":"Wohlford GF, Van Tassell BW, Billingsley HE, Kadariya D, Canada JM, Carbone S, Mihalick VL, Bonaventura A, Vecchi\u00e9 A, Chiabrando JG, Bressi E, Thomas G, Ho AC, Marawan AA, Dell M, Trankle CR, Turlington J, Markley R, Abbate A (2020) Phase 1B, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral NLRP3 inhibitor dapansutrile in subjects with NYHA II-III systolic heart failure. J Cardiovasc Pharmacol 77(1):49\u201360. https:\/\/doi.org\/10.1097\/fjc.0000000000000931","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"1579_CR137","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.chembiol.2024.04.006","volume":"31","author":"J Wu","year":"2024","unstructured":"Wu J, Sun X, Jiang P (2024) Metabolism-inflammasome crosstalk shapes innate and adaptive immunity. Cell Chem Biol 31(5):884\u2013903. https:\/\/doi.org\/10.1016\/j.chembiol.2024.04.006","journal-title":"Cell Chem Biol"},{"key":"1579_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01275-w","author":"W Xu","year":"2025","unstructured":"Xu W, Huang Y, Zhou R (2025) NLRP3 inflammasome in neuroinflammation and central nervous system diseases. Cell Mol Immunol. https:\/\/doi.org\/10.1038\/s41423-025-01275-w","journal-title":"Cell Mol Immunol"},{"key":"1579_CR139","doi-asserted-by":"publisher","first-page":"106263","DOI":"10.1016\/j.intimp.2020.106263","volume":"81","author":"S Yan","year":"2020","unstructured":"Yan S, Xuan Z, Yang M, Wang C, Tao T, Wang Q, Cui W (2020) CSB6B prevents \u03b2-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-\u03baB and NLRP3 in microglia cells. Int Immunopharmacol 81:106263. https:\/\/doi.org\/10.1016\/j.intimp.2020.106263","journal-title":"Int Immunopharmacol"},{"key":"1579_CR140","doi-asserted-by":"publisher","first-page":"108972","DOI":"10.1016\/j.intimp.2022.108972","volume":"110","author":"L Yang","year":"2022","unstructured":"Yang L, Zhou H, Huang L, Su Y, Kong L, Ji P, Sun R, Wang C, Li W, Li W (2022) Stress level of glucocorticoid exacerbates neuronal damage and A\u03b2 production through activating NLRP1 inflammasome in primary cultured hippocampal neurons of APP-PS1 mice. Int Immunopharmacol 110:108972. https:\/\/doi.org\/10.1016\/j.intimp.2022.108972","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1579_CR141","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s12035-017-0467-9","volume":"55","author":"J Yin","year":"2018","unstructured":"Yin J, Zhao F, Chojnacki JE, Fulp J, Klein WL, Zhang S, Zhu X (2018) NLRP3 inflammasome inhibitor ameliorates amyloid pathology in a mouse model of Alzheimer\u2019s disease. Mol Neurobiol 55(3):1977\u20131987. https:\/\/doi.org\/10.1007\/s12035-017-0467-9","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1579_CR142","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X (2021) Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther 6(1):128. https:\/\/doi.org\/10.1038\/s41392-021-00507-5","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"1579_CR143","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0092-8674(93)90485-9","volume":"75","author":"J Yuan","year":"1993","unstructured":"Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75(4):641\u2013652. https:\/\/doi.org\/10.1016\/0092-8674(93)90485-9","journal-title":"Cell"},{"issue":"1","key":"1579_CR144","doi-asserted-by":"publisher","first-page":"19305","DOI":"10.1038\/s41598-021-98437-3","volume":"11","author":"W Zeng","year":"2021","unstructured":"Zeng W, Wu D, Sun Y, Suo Y, Yu Q, Zeng M, Gao Q, Yu B, Jiang X, Wang Y (2021) The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages. Sci Rep 11(1):19305. https:\/\/doi.org\/10.1038\/s41598-021-98437-3","journal-title":"Sci Rep"},{"issue":"15","key":"1579_CR145","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.1111\/jcmm.16787","volume":"25","author":"L Zhai","year":"2021","unstructured":"Zhai L, Shen H, Sheng Y, Guan Q (2021) ADMSC Exo-MicroRNA-22 improve neurological function and neuroinflammation in mice with Alzheimer\u2019s disease. J Cell Mol Med 25(15):7513\u20137523. https:\/\/doi.org\/10.1111\/jcmm.16787","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1579_CR146","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/cr.2017.133","volume":"28","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Chen X, Gueydan C, Han J (2018) Plasma membrane changes during programmed cell deaths. Cell Res 28(1):9\u201321. https:\/\/doi.org\/10.1038\/cr.2017.133","journal-title":"Cell Res"},{"key":"1579_CR147","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb8680","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wang R, Hu D, Sun X, Fujioka H, Lundberg K, Chan ER, Wang Q, Xu R, Flanagan ME, Pieper AA, Qi X (2020) Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer\u2019s disease. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abb8680","journal-title":"Sci Adv"},{"issue":"1","key":"1579_CR148","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12974-021-02295-9","volume":"18","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Bai H, Ma X, Shen M, Li R, Qiu D, Li S, Gao L (2021) Blockade of the NLRP3\/caspase-1 axis attenuates ketamine-induced hippocampus pyroptosis and cognitive impairment in neonatal rats. J Neuroinflammation 18(1):239. https:\/\/doi.org\/10.1186\/s12974-021-02295-9","journal-title":"J Neuroinflammation"},{"key":"1579_CR149","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cytogfr.2024.10.004","volume":"80","author":"MJ Zhang","year":"2024","unstructured":"Zhang MJ, Yang L, Li ZY, Zhou LY, Wang YJ, Wang HS, Cui XJ, Yao M (2024a) NLRP1 inflammasome in neurodegenerative disorders: from pathology to therapies. Cytokine Growth Factor Rev 80:138\u2013155. https:\/\/doi.org\/10.1016\/j.cytogfr.2024.10.004","journal-title":"Cytokine Growth Factor Rev"},{"key":"1579_CR150","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2024.09.038","volume":"225","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Chen H, Han L, Liu K, Du S, Gao R (2024b) Inhibition of the NLRP3\/caspase-1 cascade related pyroptosis relieved propofol-induced neuroinflammation and cognitive impairment in developing rats. Free Radical Biol Med 225:87\u201397. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.09.038","journal-title":"Free Radical Biol Med"},{"key":"1579_CR151","doi-asserted-by":"publisher","first-page":"721474","DOI":"10.3389\/fnagi.2021.721474","volume":"13","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Tan SW, Huang ZZ, Shan FB, Li P, Ning YL, Ye SY, Zhao ZA, Du H, Xiong RP, Yang N, Peng Y, Chen X, Zhou YG (2021) NLRP3 inflammasome-dependent increases in high mobility group box 1 involved in the cognitive dysfunction caused by Tau-overexpression. Front Aging Neurosci 13:721474. https:\/\/doi.org\/10.3389\/fnagi.2021.721474","journal-title":"Front Aging Neurosci"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01579-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-025-01579-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01579-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:24:16Z","timestamp":1765535056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-025-01579-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":151,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1579"],"URL":"https:\/\/doi.org\/10.1007\/s10571-025-01579-5","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"57"}}